These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38529786)

  • 21. Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study.
    Langhof H; Chin WWL; Wieschowski S; Federico C; Kimmelman J; Strech D
    Br J Pharmacol; 2018 Nov; 175(22):4229-4238. PubMed ID: 30153701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
    Boesen K; Gøtzsche PC; Ioannidis JPA
    Epidemiol Psychiatr Sci; 2021 Apr; 30():e35. PubMed ID: 33926608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversified harmony: supranational and domestic regulation of pediatric clinical trials in the European Union.
    Pinxten W; Dierickx K; Nys H
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S183-98. PubMed ID: 21658637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.
    Iglesias-Lopez C; Obach M; Vallano A; Agustí A
    Cytotherapy; 2021 Mar; 23(3):261-274. PubMed ID: 33483292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
    Reinisch W; Gottlieb K; Colombel JF; Danese S; Panaccione R; Panes J; Peyrin-Biroulet L; Rubin D; Sands BE; Schreiber S; Vermeire S; Mulberg A; Sandborn B
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1673-1679.e1. PubMed ID: 31352970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Master protocols in clinical trials: a universal Swiss Army knife?
    Sudhop T; Brun NC; Riedel C; Rosso A; Broich K; Senderovitz T
    Lancet Oncol; 2019 Jun; 20(6):e336-e342. PubMed ID: 31162107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.
    Peeva E; Banerjee A; Banfield C; Soma K; Christensen J; Menon S; Vincent MS; Dolsten M
    Drug Discov Today; 2024 May; 29(5):103948. PubMed ID: 38460567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions.
    Perucca E
    CNS Drugs; 2008; 22(11):917-38. PubMed ID: 18840033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethical review of patient safety and public health in EU clinical trials legislation: impact of COVID-19 pandemic.
    Olimid AP; Olimid DA
    Rom J Morphol Embryol; 2020; 61(1):277-281. PubMed ID: 32747923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to facilitate adolescent access to medicines: Improving regulatory guidance.
    Bucci-Rechtweg C; Siapkara A; An Haack Bonnet K; Corriol Rohou S; Haf Davies E; Dehlinger Kremer M; Gamalo M; Moreno C; Nelson RM; Thomas Turner R
    Clin Trials; 2023 Feb; 20(1):13-21. PubMed ID: 36341541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries.
    Hartmann M
    Trials; 2012 Apr; 13():53. PubMed ID: 22540886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Input analysis for two public consultations on the EU Clinical Trials Regulation.
    Langhof H; Lander J; Strech D
    Health Res Policy Syst; 2016 Sep; 14(1):69. PubMed ID: 27639695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the European clinical trials directive really improve clinical trial approval time?
    Lambers Heerspink HJ; Dobre D; Hillege HL; Grobbee DE; de Zeeuw D
    Br J Clin Pharmacol; 2008 Oct; 66(4):546-50. PubMed ID: 18662290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials.
    DeGeorge J; Robertson S; Butler L; Derzi M; Stoch SA; Diaz D; Hartke J; Guzzie-Peck P; Mortimer-Cassen E; Bogdanffy M; Will Y; Greene N
    Clin Pharmacol Ther; 2018 Apr; 103(4):566-569. PubMed ID: 29285748
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.